Amarapurkar A, Ghansar T

Idioma: Ingles.
Referencias bibliográficas: 23
Paginas: 37-40
Archivo PDF: 70.38 Kb.

FRAGMENTO

No tiene resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Mofrad Ps, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ. Clinical and histological spectrum of non alcoholic fatty liver disease associated with normal ALT valves. Hepatology 2003; 37: 1286-92.

2. Brunt Em. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 3-16.

3. Wedemeyer H, Manns MP. Fatty liver disease It’s more than alcohol and obesity. Medscape Gastroenterology 2003; 5(2).

4. Amarapurkar DN, Amarapurkar AD. Non alcoholic steatohepatitis: Clinicological profile. J Assoc Physicians India 2000; 48: 311-313.

5. Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis 2004; 24: 349-362.

6. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: The dionysos nutrition and liver study. Hepatology 2005; 42:44-52.

7. Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, Kim KR, Lee HC, Huh SB, Cha BS. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004; 164: 2169-75.

8. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-117.

9. James O, Day P. Nonalcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998; 29: 495-501.

10. Czaja A, Carpenter H, Santroch P, et al. Host and disease specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998; 29: 198-206.

11. Singh SP, Nayak S, Swain M, Rout N, Mallik RN, Agrawal O, Meher C, Rao M. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol 2004; 25: 76-9.

12. Leevy CM. A study of 270 patients with biopsy proven fatty liver and a review of the literature. Medicine (Baltimore) 1962; 41: 249-76.

13. Sherlock S, Dooley J. Nutritional and metabolic liver diseases. In: Sherlock S, Pooley J eds. Diseases of the liver and biliary system. Blackwell Science Ltd, 1997: 427-453.

14. Gupta S, Meena HS, Chopra R. Hepatic involvement in tuberculosis. Journal of Association of Physicians of India 1993; 41: 20-22.

15. Thulstrup Am, Molle I, Svendsen N, Sorenson HT. Incidence and prognosis of tuberculosis in patients with cirrhosis of the liver. A Danish nationwide population based study. Epidemiol Infect 2000; 124: 221-225.

16. Rathi PM, Amarapurkar DN, Borges NE, Koppikar GV, Kalro RH. Spectrum of liver diseases in HIV infection. Indian J Gastroenterology 1997; 16: 94-5.

17. Poonawala A, Nair Sp, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis. Hepatology 2000; 32: 689-692.

18. Caldwell SH, Oelsner DH, Lessoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: Clinical and risk factors for underlying disease. Hepatology 1999; 29: 664-669.

19. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-1110.

20. Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L, Bolondi L. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 2004; 53: 1020-1023.

21. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.

22. Rozario R, Ramakrishna B. Histopathological study of chronic hepatitis B and C: a comparison of two scoring system. J Hepatol 2003; 38: 223-9.

23. Amarapurkar AD, Sangle NA. Histological spectrum of liver in HIV - autopsy study. Ann Hepatol 2005; 4: 47-51.